Kainos Medicine, Inc. (KOSDAQ: A284620)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
Kainos Medicine, Inc. (KOSDAQ: A284620) operates in the Biotechnology industry within the Health Care sector. The company is valued at $25.58M.
trading between 960.00 and 6.00K.
Tweenvest scores Kainos Medicine, Inc. across four factors: quality 36/100, value 50/100. Its strongest factor is value.
A284620 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.58M
- Revenue (TTM)
- $907.04K
- P/E
- —
- EPS
- -193.51
- Dividend yield
- —
- Beta (5Y)
- 0.97
- 52-week high
- ₩6,000.00
- 52-week low
- ₩960.00
- Avg volume (3M)
- —
- Shares outstanding
- 32.71M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Atossa Therapeutics, Inc.NasdaqCM: ATOS | $25.95M | $2.60 | -4.41% |
| Noile-Immune Biotech Inc.TSE: 4893 | $25.84M | ¥94.00 | -7.84% |
| Seoulin Bioscience Co.,Ltd.KOSDAQ: A038070 | $25.81M | ₩3,810.00 | -6.39% |
| Genesystem Co., Ltd.KOSDAQ: A363250 | $25.76M | ₩4,145.00 | +1.97% |
| D. Western Therapeutics Institute, Inc.TSE: 4576 | $25.15M | ¥69.00 | -1.43% |
| Immutep LimitedASX: IMM | $24.85M | AU$0.02 | +4.35% |
| Genvor IncorporatedOTCPK: GNVR | $24.85M | $0.68 | -24.17% |
| Thiogenesis Therapeutics, Corp.TSXV: TTI | $24.74M | CA$0.50 | -5.66% |
Figures last refreshed Oct 18, 2026.